Citadel Advisors’s Arotech Corporation ARTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-20,100
Closed -$71K 8331
2017
Q2
$71K Buy
20,100
+8,200
+69% +$27K ﹤0.01% 7009
2017
Q1
$35K Buy
+11,900
New +$46K ﹤0.01% 7133
2014
Q3
Sell
-500
Closed -$2K 8572
2014
Q2
$2K Buy
+500
New +$2.13K ﹤0.01% 7847

Citadel Advisors's ARTX Position: Q4 2019 in Review

Citadel Advisors sold out of Arotech Corporation (ARTX) in Q4 2019, closing a stake of 25,754 shares — an estimated $76K sold.

Citadel Advisors first reported a position in ARTX in Q3 2013 and held it in 17 quarters. The position peaked at $178K in Q4 2017. 0 funds tracked by Wall St. Rank hold ARTX as of Q4 2019.

  • Citadel Advisors reported no remaining Arotech Corporation position as of Q4 2019 after selling out during the quarter.
  • Citadel Advisors sold 25,754 Arotech Corporation shares in Q4 2019, an estimated $76K.
  • Citadel Advisors first reported a position in Arotech Corporation in Q3 2013 and held it in 17 quarters.
  • Citadel Advisors's Arotech Corporation position peaked at $178K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Arotech Corporation as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.